Pterostilbene vs Resveratrol: Bioavailability Changes Everything
Pterostilbene has 80% oral bioavailability vs resveratrol's under 1%. Here is what that means for longevity dosing — and why most resveratrol supplements are marketing.
Quick Verdict
Pterostilbene and resveratrol are structurally nearly identical polyphenols — both activate SIRT1 and share most cellular targets. The difference is bioavailability: oral pterostilbene shows ~80% systemic availability vs oral resveratrol at <1% due to heavy first-pass glucuronidation in the liver. In practical terms, 100 mg of pterostilbene delivers more active compound to tissues than 500-1000 mg of standard resveratrol. Pterostilbene is the evidence-backed pick for longevity dosing; resveratrol remains useful only when combined with absorption enhancers like piperine or delivered in specialized forms (trans-resveratrol + phospholipid complex).
Side-by-side
| Pterostilbene | Resveratrol | |
|---|---|---|
| Structural class | Trans-stilbene polyphenol | Trans-stilbene polyphenol |
| Natural source | Blueberries, grapes | Red wine, grape skins, Japanese knotweed |
| Oral bioavailability | ~80% | <1% (standard form) |
| Half-life | ~105 minutes | ~14 minutes |
| SIRT1 activation | Yes | Yes |
| NAD+ context | Works with NAD precursors | Works with NAD precursors |
| Typical dose | 50-100 mg/day | 150-500 mg/day (or 1000+ for bioavailable forms) |
| Primary evidence base | Smaller (newer) | Larger (older, partly human-flawed) |
| Cost per effective dose | Moderate | Often higher if you account for wasted dose |
Why Bioavailability Dominates
Resveratrol's bioavailability problem is severe. Within 30-60 minutes of oral dosing, the liver conjugates it to glucuronide and sulfate metabolites that are largely inactive for the SIRT1 pathway. By the time blood levels are measured, less than 1% of the dose is in its active trans-resveratrol form.
Pterostilbene has two methyl groups where resveratrol has hydroxyls. That small structural difference:
- Resists hepatic glucuronidation
- Extends plasma half-life from ~14 minutes to ~105 minutes
- Delivers measurable active compound to peripheral tissues
The result: a 100 mg pterostilbene dose outperforms a 1000 mg standard-resveratrol dose on almost every pharmacokinetic metric. If you're taking resveratrol for SIRT1 activation, the math favours pterostilbene unless you pair resveratrol with absorption enhancers.
What Both Do Share
- SIRT1 activation — both compounds engage the NAD+-dependent sirtuin pathway, with downstream effects on mitochondrial biogenesis, stress resistance, and metabolic signaling
- Antioxidant capacity — both scavenge reactive oxygen species and reduce oxidative damage in vitro
- Anti-inflammatory effect — both reduce NF-κB-driven cytokine production
- Positive effects on glucose regulation — both improve fasting glucose and insulin sensitivity in small human trials
- Interact with NAD+ precursors (NMN, NR) — commonly stacked in longevity protocols
Where Pterostilbene Has Advantages
- Systemic delivery — 80x more oral bioavailability translates to real tissue concentrations
- Dose convenience — 50-100 mg daily is adequate vs 500+ mg for standard resveratrol
- LDL cholesterol reduction — pterostilbene shows consistent effect in small trials; resveratrol's data here is mixed
- Brain penetration — pterostilbene crosses the blood-brain barrier more readily
- Shorter but more usable half-life — consistent peaks rather than a lot of inactive metabolites
Where Resveratrol Still Wins
- Larger evidence base — decades of trials, even if many used insufficient bioavailability
- Natural dietary availability — red wine, peanuts, grape skins provide small daily doses
- Better-characterized safety — longer human exposure history
- Combined with piperine or phospholipid delivery — modern "bioavailable" resveratrol products (e.g. ResVida, Veri-te) substantially narrow the bioavailability gap
Longevity-Protocol Dosing
Typical David Sinclair-style longevity protocol includes:
- Pterostilbene 100 mg daily (morning, with fat)
- NMN or NR 300-500 mg daily (morning)
- Metformin (if prescribed) or berberine 500 mg 2-3x daily
- Omega-3 (EPA+DHA) 1-2g daily
- Vitamin D3 2000-5000 IU daily
- Magnesium glycinate 200-400 mg evening
Pterostilbene has effectively replaced resveratrol in most modern longevity stacks because of bioavailability — though both compounds appear in some older-generation protocols.
Safety and Caution
- Pterostilbene is generally well-tolerated at 100-250 mg/day
- Higher-dose resveratrol (>1 g/day) has shown mild gastrointestinal effects
- Both interact with CYP450 metabolism — check with your prescriber if you're on blood thinners, statins, or immunosuppressants
- Neither replaces proven interventions: sleep, exercise, diet, weight management, and UV protection do more for biological age than any polyphenol
Who Should Skip Both
- Pregnancy or breastfeeding
- Children
- People on warfarin or other anticoagulants (polyphenols can potentiate)
- People with active hormone-sensitive cancers (both have weak estrogenic activity in vitro)
- People expecting dramatic results — polyphenols are maintenance interventions, not transformations
Frequently Asked Questions
Is pterostilbene better than resveratrol?
For systemic effect from an oral supplement, pterostilbene is substantially better because of 80% bioavailability vs resveratrol's under 1%. A 100 mg pterostilbene dose delivers more active compound to tissues than 1000 mg of standard resveratrol. Pterostilbene has replaced resveratrol in most modern longevity protocols.
Can you take pterostilbene and resveratrol together?
Yes — they act on overlapping but not identical pathways, and combining them is safe. The practical question is cost-benefit: if you're already taking 100 mg pterostilbene, the marginal benefit of adding 500 mg resveratrol is small. Many longevity protocols simplify to pterostilbene alone.
What is the best dose of pterostilbene?
50-100 mg daily, taken in the morning with a fat-containing meal to improve absorption. Higher doses (250+ mg) don't show proportional additional benefit in published trials and can cause mild LDL-cholesterol changes in some individuals. Start at 50 mg for two weeks, then 100 mg long-term.
Does pterostilbene activate sirtuins like resveratrol?
Yes. Pterostilbene activates SIRT1 via the same mechanism as resveratrol — both compounds bind the activator site on the sirtuin enzyme. Because pterostilbene reaches peripheral tissues at meaningful concentrations while resveratrol largely doesn't, pterostilbene produces measurable downstream sirtuin-pathway effects at lower oral doses.
Bottom Line
Pterostilbene's bioavailability advantage over resveratrol is so large that it effectively makes the comparison moot for oral supplementation. For longevity-protocol SIRT1 activation, pterostilbene at 100 mg/day delivers what resveratrol at 1 g/day attempts. Resveratrol remains useful only in absorption-enhanced forms (piperine, phospholipid delivery) or from dietary sources. For most patients, pterostilbene replaces standard resveratrol without loss of benefit.
